Malaria
Market Access/ News/ News/ News/ Patients
GSK pledges £1bn drive for infectious disease R&D
Phil Taylor
developing countries, GlaxoSmithKline, HIV, infectious diseases, Malaria, Novartis, patients, tropical diseases, tuberculosis
0 Comment
GSK’s malaria vaccine gets WHO okay for mass rollout
Phil Taylor
GlaxoSmithKline, infectious disease, Malaria, parasitology, vaccine, World Health Organisation
0 Comment
Novartis drug raises hope of tackling malaria drug resistance
Phil Taylor
Coartem, ganaplacide, infectious disease, Malaria, Novartis, parasitology
0 Comment
More malaria hope as NIH antibody protects against infection
Phil Taylor
antibody, infectious disease, Malaria, NIAID, NIH, parasitology, R&D
0 Comment
BioNTech’s mRNA vaccine drive now includes malaria, TB shots
Phil Taylor
BioNTech, Malaria, mRNA, tuberculosis, vaccines
0 Comment
Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy
Richard Staines
infectious diseases, Malaria, R&D, vaccine
0 Comment
News/ News/ R&D/ Top stories/ US
Bill and Melinda Gates start not-for-profit biotech
Richard Staines
Bill and Melinda Gates Medical Research Institute, Bill Gates, Biotech, diarrhoea, Gates Foundation, infectious diseases, Malaria, tuberculosis
0 Comment
Biotech will focus on diseases such as TB